Menu

ImmunityBio, Inc. IBRX

Full chart Compare
Set alert

Price alert · IBRX

All alert types
6.67 USD -0.08 (-1.11%)

At closeNov 11, 2026, 7:48 PM EST

6.63 -0.04 -0.60%

After hours · Nov 11, 7:48 PM ET

6.51 Day range 6.85
1.95 52-week range 12.43
YTD
+236.87%
1 year
+211.68%

Discussion (3500)

Sign in to join the discussion

Lawrence Mcdonald IBRX 3 years ago #3412

Hot money that pushed this up will exit quickly after PSS has his chat so have your finger on the trigger if he just cajoles and says a whole lot of nothing because we head back fast and furious to 2.50-2.75

Lawrence Mcdonald IBRX 3 years ago #3415

It’s a thing that’s been happening since the rotation out of biotech. The powerhouse shorts know that the sector if boom or bust and prey on them moving them back and forth. The key is here we have a breakthrough therapy that will catapult this stock into a different class.

Lawrence Mcdonald IBRX 3 years ago #3417

The cancer moonshot under Biden is the key to this. The FDA can and will approve Anktiva because as I said it would be criminal not to.

Lawrence Mcdonald IBRX 3 years ago #3418

So if he converts I’d say we have a clear picture of where IBRX is headed. I say 8-10 by Xmas. The history of blockbuster biotech drugs is there to look at. The dynamic evolution and interest in Aktiva will be one for the books.

Lawrence Mcdonald IBRX 3 years ago #3420

Back and forth but on news it’s gone in either direction. So if you like adventure kick back and like Hertz… “ Leave the driving to us”